| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | Can-Fite BioPharma Ltd. | 653,946 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | CVI Investments, Inc. | Can-Fite BioPharma Ltd. | 23,161,650 | 3.7% | EDGAR |
| SC 13G/A | 2022-02-11 | INTRACOASTAL CAPITAL, LLC | Can-Fite BioPharma Ltd. | 39,495,437 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-04 | Hudson Bay Capital Management LP | Can-Fite BioPharma Ltd. | 24,384,150 | 4.1% | EDGAR |
| SC 13G/A | 2021-02-16 | CVI Investments, Inc. | Can-Fite BioPharma Ltd. | 23,161,650 | 5.0% | EDGAR |
| SC 13G/A | 2021-02-09 | Hudson Bay Capital Management LP | Can-Fite BioPharma Ltd. | 24,384,150 | 5.0% | EDGAR |
| SC 13G/A | 2021-01-29 | INTRACOASTAL CAPITAL, LLC | Can-Fite BioPharma Ltd. | 32,911,650 | 6.6% | EDGAR |
| SC 13G | 2020-06-19 | ARMISTICE CAPITAL, LLC | Can-Fite BioPharma Ltd. | 719,980 | 5.0% | EDGAR |
| SC 13G | 2020-06-19 | CVI Investments, Inc. | Can-Fite BioPharma Ltd. | 29,268,300 | 7.1% | EDGAR |
| SC 13G | 2020-02-20 | ARMISTICE CAPITAL, LLC | Can-Fite BioPharma Ltd. | 390,720 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Anson Funds Management LP | Can-Fite BioPharma Ltd. | 721,644 | 0.6% | EDGAR |
| SC 13G/A | 2020-02-11 | INTRACOASTAL CAPITAL, LLC | Can-Fite BioPharma Ltd. | 364,103 | 8.3% | EDGAR |
| SC 13G | 2020-01-31 | Hudson Bay Capital Management LP | Can-Fite BioPharma Ltd. | 9,750,000 | 7.5% | EDGAR |
| SC 13G/A | 2020-01-08 | SABBY MANAGEMENT, LLC | Can-Fite BioPharma Ltd. | 5,970,834 | 5.0% | EDGAR |
| SC 13D/A | 2019-10-24 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 5,509,260 | - | EDGAR |
| SC 13D/A | 2019-10-17 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 12,844,020 | - | EDGAR |
| SC 13D/A | 2019-09-11 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 12,844,020 | - | EDGAR |
| SC 13D/A | 2019-08-08 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 12,844,020 | - | EDGAR |
| SC 13D/A | 2019-07-10 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 12,844,020 | - | EDGAR |
| SC 13D/A | 2019-06-14 | Capital Point Ltd. | Can-Fite BioPharma Ltd. | 11,971,020 | - | EDGAR |